Lifeboat Foundation

https://www.youtube.com/watch?v=Z615ODj0juM

This video was made possible by Brilliant. Be one of the first 200 people to sign up with this link and get 20% off your premium subscription with Brilliant.org! https://brilliant.org/singularity

Artificial intelligence, machine learning – these words lately have been used synonymously – but should they be?

Continue reading “What Is Machine Learning (Supervised Learning) — Part 1” »

I’m a actually really excited because I have a special surprise for everyone. Remember last year when I gave away all those stabs for free? This is even better.

How much better? I’m willing to smack a bunch of their links into my post here.

BTW, it’s in Vegas. I mean… C’mon.

On January 20^th Google’s DeepMind division, the division behind a myriad of artificial intelligence (AI) firsts, quietly submitted a paper on Arxiv entitled “PathNet: Evolution Channels Gradient Descent in Super Neural Networks” that mostly went unnoticed.

The cryonics debate explained, plus new issues in waking the dead. Would cryonics customers even be welcomed in the future?

The Life Extension Advocacy Foundation, a nonprofit organization dedicated to promoting healthy longevity and aging research through crowdfunding and advocacy initiatives, is hosting its second annual scientific conference, Ending Age-Related Diseases: Investment Prospects and Advances in Research, at the Cooper Union in New York City on July 11th-12th.

The goal of this conference is to promote collaboration between academia, biotech companies, investors, regulators, public health advocates, and doctors in order to foster the creation of interventions to relieve our aging society from the burden of age-related diseases. It is supported by Genome Protection Inc., which is developing therapies to counteract harmful viral elements in our genome that provoke chronic inflammation, and Icaria Life Sciences Inc., which provides contract research in the field of geroscience.

The morbidity from chronic age-related diseases is increasing proportionally to the aging of the global population, representing a challenge to social protection and healthcare systems around the world. The development of next-generation drugs and therapies that could directly target the processes of aging to more effectively prevent and cure age-related diseases has now become a priority, yet the industry is clearly facing unique financial, development, and regulatory bottlenecks.

The rabbit-sized heart was made from a patient’s own cells and tissues, using techniques that could help to increase the rate of successful heart transplants in future.

How it worked: A biopsy of tissue was taken from patients, and then its materials were separated. Some molecules, including collagen and glycoproteins, were processed into a hydrogel, which became the printing “ink.” Once the hydrogel was mixed with stem cells from the tissue, the researchers from Tel Aviv University were able to create a patient-specific heart that included blood vessels. The idea is that such a heart would be less likely to be rejected when transplanted. The study was published in the journal Advanced Science.

Let it flow: Until now, researchers have only been able to print simple tissues lacking blood vessels, according to the Jerusalem Post.

The discovery that apparently dead cells can sometimes resurrect themselves has researchers exploring how far they can push the point of no return.

Summary: Gene therapy can restore the structure of the retina and regain normal light responses. Source: SfNFollowing gene therapy, the retina can restructure itself and regain normal light res.